UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 153

Sortiert nach

IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models

Blood, 2016-12, Vol.128 (23), p.2683-2693

2016

Volltextzugriff (PDF)

Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro

Journal of bone and mineral metabolism, 2012-01, Vol.30 (1), p.119-123

2012

Volltextzugriff (PDF)

Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia

Haematologica (Roma), 2008-07, Vol.93 (7), p.1101-1103

2008

Volltextzugriff (PDF)

Serum levels of LIGHT in MS

Multiple sclerosis, 2013-06, Vol.19 (7), p.871-876

2013

Volltextzugriff (PDF)

Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura

Thrombosis and haemostasis, 2005-01, Vol.93 (1), p.139

2005

Volltextzugriff (PDF)

MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP)

Blood, 2013-03, Vol.121 (11), p.2095-2098

2013

Volltextzugriff (PDF)

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

The New England journal of medicine, 2010-06, Vol.362 (24), p.2251-2259

2010

Volltextzugriff (PDF)

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Blood, 2008-04, Vol.111 (8), p.4022-4028

2008

Volltextzugriff (PDF)

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Blood, 2013-08, Vol.122 (7), p.1284-1292

2013

Volltextzugriff (PDF)

Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1

Blood, 2008-08, Vol.112 (4), p.1078-1084

2008

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry

British journal of haematology, 2021-06, Vol.193 (5), p.915-921

2021

Volltextzugriff (PDF)

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

British journal of haematology, 2015-06, Vol.169 (5), p.683-688

2015

Volltextzugriff (PDF)

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

Nature medicine, 2003-09, Vol.9 (9), p.1123-1124

2003

Volltextzugriff (PDF)

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)

BMC immunology, 2013-07, Vol.14 (1), p.32-32, Article 32

2013

Volltextzugriff (PDF)

Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study

Annals of hematology, 2017-08, Vol.96 (8), p.1419-1419

2017

Volltextzugriff (PDF)

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

American journal of hematology, 2022-04, Vol.97 (4), p.421-430

2022

Volltextzugriff (PDF)

Diagnostic and Differential Criteria of Essential Thrombocythemia and Reactive Thrombocytosis

Leukemia & lymphoma, 1996-01, Vol.22 (S1), p.41-45

1996

Volltextzugriff (PDF)

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice

European journal of haematology, 2017-02, Vol.98 (2), p.112-120

2017

Volltextzugriff (PDF)

Differential expression of T-cell genes in blood and bone marrow between ITP patients and controls

Thrombosis and haemostasis, 2013-01, Vol.109 (1), p.112

2013

Volltextzugriff (PDF)

Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia

Thrombosis and haemostasis, 2012-06, Vol.107 (6), p.1182

2012

Volltextzugriff (PDF)

Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study

Annals of hematology, 2012-05, Vol.91 (5), p.679-685

2012

Volltextzugriff (PDF)

Moving towards a new era in the management of chronic immune thrombocytopenia

Annals of hematology, 2010-07, Vol.89 (1), p.87-93

2010

Volltextzugriff (PDF)

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Cancer, 2009-02, Vol.115 (3), p.551-560

2009

Volltextzugriff (PDF)

Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP

Blood, 2013-09, Vol.122 (10), p.1789-1792

2013

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(152)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(121)
Life Sciences & Biomedicine
(99)
Science & Technology
(99)
Hematology
(85)
Male
(85)
Clinical Medicine
(77)
Klinisk Medicin
(76)
Adult
(75)
Female
(75)
Biological And Medical Sciences
(70)
Middle Aged
(70)
Aged
(61)
Medical Sciences
(59)
Blood
(47)
Blood Platelets
(39)
Hematologi
(34)
Hematologic And Hematopoietic Diseases
(28)
Immunology
(28)
Physiology
(28)
Platelet Count
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models

Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro

Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia

Serum levels of LIGHT in MS

Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura

MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP)

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)

Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

Diagnostic and Differential Criteria of Essential Thrombocythemia and Reactive Thrombocytosis

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice

Differential expression of T-cell genes in blood and bone marrow between ITP patients and controls

Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia

Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study

Moving towards a new era in the management of chronic immune thrombocytopenia

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP

Suchergebnisse filtern